- VC-style research lens applied to public markets
- Inception: 06/30/2005
- Rebalance: Quarterly
- Approx. turnover: ~15–20% (approx.)
- Calculated by: Refinitiv (LSEG)
| Type Index |
| Inception Date 06/30/2005 |
ER30TR applies a venture-capital lens to public markets, built on 20+ years of research. The proprietary Entrepreneur Factor® framework evaluates companies across 18 proprietary attributes designed to surface entrepreneurial leadership and innovation characteristics. The index is rules-based and rebalanced quarterly to maintain disciplined exposure over time.
As of: 03.31.2026
| Index Performance Chart As of 03/31/2026 |
| NAV | $- |
| Market Price | $- |
| Information Technology 38.75% |
| Health Care 18.10% |
| Communication Services 16.47% |
| Financials 13.85% |
| Consumer Discretionary 6.79% |
| Industrials 6.04% |
Sector Allocations are subject to change
* All performance figures shown are annualized.
The ERShares ER30TR Index selects the most entrepreneurial, primarily US Large Cap companies, that meet the threshold embedded in the proprietary Entrepreneur Factor® (EF). It is not possible to invest directly in the Index, and past performance does not guarantee future results. Investors should conduct their own research and consider the risks associated with any investments linked to the Index.
Disclosures
ER30TR Index Disclosure:
The ERShares ER30TR Index selects the most entrepreneurial, primarily US Large Cap companies, that meet the threshold embedded in the proprietary Entrepreneur Factor® (EF). It is not possible to invest directly in the Index, and past performance does not guarantee future results. Investors should conduct their own research and consider the risks associated with any investments linked to the Index.
We have received many questions regarding Fidelity's transaction-based service fee on purchases of XOVR.
As investor interest and trading activity in XOVR have increased significantly, Fidelity has included XOVR among a limited number of ETFs subject to a fee of up to $100.
This fee is determined and collected solely by Fidelity. It is not charged by XOVR or ERShares and does not benefit the fund. XOVR may be available through other brokerage platforms without this fee.
Please review your brokerage firm's current fee schedule before investing. Brokerage fees and availability are subject to change.
Subscribe to our newsletter to stay updated about the global markets.